Results for
""Fees, Pharmaceutical""[mesh_terms]

After the diagnosis: adherence and persistence with hypertension therapy.

The American journal of managed care 2007;11(13 Suppl):S395-9

Evaluation of medical costs associated with use of new oral anticoagulants compared with standard therapy among venous thromboembolism patients.

Alpesh Amin, Yonghua Jing, Jeffrey Trocio, Jay Lin, Melissa Lingohr-Smith, John Graham

Journal of medical economics 2015;17(11):763-70

Heart failure patient adherence: epidemiology, cause, and treatment.

David J Whellan, Suzanne Adams, Paul S Corotto, Melissa M McCarey, Prateeti Khazanie

Heart failure clinics 2013;9(1):49-58

The application of evidence-based principles of care in older persons (issue 1): management of osteoporosis.

Barbara J Zarowitz, Richard Stefanacci, Kelly Hollenack, Terry O'Shea

Journal of the American Medical Directors Association 2007;8(3 Suppl 2):e51-7

Real-world dosing and drug costs with everolimus or axitinib as second targeted therapies for advanced renal cell carcinoma: a retrospective chart review in the US.

Nicholas J Vogelzang, Jose Ricardo Perez, Zhimei Liu, Nanxin Li, William M Reichmann, James E Signorovitch, Eric Jonasch, Sumanta K Pal

Journal of medical economics 2017;19(5):462-8